NuvaRing

GPTKB entity

Statements (40)
Predicate Object
gptkbp:instanceOf gptkb:brand
contraceptive device
gptkbp:activeIngredient gptkb:etonogestrel
ethinylestradiol
gptkbp:approvalYear 2001
gptkbp:approvedBy gptkb:FDA
gptkbp:canBeStoredAtRoomTemperature up to 4 months
gptkbp:category hormonal contraceptive
gptkbp:duration 3 weeks per cycle
gptkbp:effect about 91% with typical use
over 99% with perfect use
gptkbp:genericAvailable yes
gptkbp:genericName gptkb:etonogestrel/ethinylestradiol_vaginal_ring
https://www.w3.org/2000/01/rdf-schema#label NuvaRing
gptkbp:insertionFrequency once every 4 weeks
gptkbp:manufacturer gptkb:Organon
gptkbp:marketedIn gptkb:Australia
gptkb:Canada
gptkb:Europe
gptkb:United_States
gptkbp:notRecommendedFor women over 35 who smoke
women with history of blood clots
gptkbp:prescriptionStatus prescription only
gptkbp:productType vaginal ring
gptkbp:removalFrequency once every 3 weeks
gptkbp:riskFactor heart attack
stroke
blood clots
gptkbp:routeOfAdministration vaginal
gptkbp:sideEffect nausea
headache
breast tenderness
mood changes
vaginal irritation
gptkbp:storage 2-8°C (refrigerated)
gptkbp:usedFor birth control
contraception
gptkbp:website https://www.nuvaring.com/
gptkbp:bfsParent gptkb:MRK
gptkbp:bfsLayer 5